Phase I trial of remimazolam to assess the abuse potential

Trial Profile

Phase I trial of remimazolam to assess the abuse potential

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2017

At a glance

  • Drugs Remimazolam (Primary)
  • Indications Sedation
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Nov 2017 According to a PAION media release, recruitment of this trial was completed in the second quarter of 2017.
    • 14 Nov 2017 Status changed from recruiting to active, no longer recruiting, according to a PAION media release.
    • 09 Aug 2017 According to a PAION media release, part 1 with twelve subject successfully completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top